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Antimyeloperoxidase antibodies can cause crescentic
glomerulonephritis and pulmonary hemorrhage. Toll-like
receptors (TLRs) respond to infectious agents activating host
defenses, whereas infections potentially initiate disease and
provoke relapses. Neutrophils were found to be key effector
cells of injury in experimental models, as disease does not
occur in their absence and injury is enhanced by
lipopolysaccharide (LPS). In this study, highly purified LPS
(a pure TLR4 ligand) acted with antimyeloperoxidase
antibodies to synergistically increase kidney and lung
neutrophil recruitment and functional injury; effects abrogated
in TLR4-deficient mice. Increased kidney TLR4 expression after
stimulation predominantly occurred in glomerular endothelial
cells. Enhanced glomerular neutrophil recruitment correlated
with increased kidney mRNA expression of CXCL1 and CXCL2
(homologs of human CXCL8), whereas their preemptive
neutralization decreased neutrophil recruitment. Disease
induction in bone marrow chimeric mice showed that TLR4 in
both bone marrow and renal parenchymal cells is required for
maximal neutrophil recruitment and glomerular injury. Further
studies in human glomerular cell lines stimulated with LPS
found that glomerular endothelial cells were the prominent
sources of CXCL8. Thus, our results define a role for TLR4
expression in bone marrow–derived and glomerular
endothelial cells in neutrophil recruitment and subsequent
functional and histological renal injury in experimental
antimyeloperoxidase glomerulonephritis.
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Small vessel vasculitis and pauci-immune necrotizing
glomerulonephritis (GN) induced by antineutrophil cyto-
plasmic antibodies (ANCAs) target specific neutrophil
cytoplasmic antigens, myeloperoxidase (MPO), and protei-
nase 3.1,2 Combined renal and pulmonary disease is common
in ANCA vasculitis and has considerable morbidity and
mortality. Experimental animal studies have shown that
ANCA are pathogenic. Passive transfer of ANCA can induce
necrotizing GN and/or pulmonary capillaritis.3–7 Links
between infection and ANCA vasculitis are well established.
Seasonal variation in patients presenting with the disease
suggests a correlation with microbial infection,8 infection
may predate disease initiation and/or relapse9–12 and pro-
phylactic antibiotic therapy has also been shown to success-
fully decrease disease relapses in ANCA vasculitis.13 Infection
is likely to be important in experimental ANCA models and
lipopolysaccharide (LPS) dose dependently increases renal
injury after the passive transfer of MPO–ANCA.6
Neutrophils are amongst the first immune cells to traffic
to inflamed sites. In experimental ANCA-induced GN
neutrophils are the primary effector cells and neutrophil
depletion protects mice from renal injury.4 In humans, the
chemokine CXCL8 (interleukin-8) is a potent neutrophil
chemoattractant.14 Renal biopsies from patients with ANCA
disease demonstrated positive CXCL8 immunostaining in
crescentic glomerular lesions, suggesting that CXCL8 con-
tributes to glomerular injury seen in ANCA-associated GN.15
The murine chemokines CXCL1 (KC) and CXCL2 (MIP-2),
that bind to CXCR2, are homologs of human CXCL816 and
serve as major chemoattractants for neutrophils in mice.17
Toll-like receptors (TLRs) recognize pathogen associated
molecular patterns from infectious agents and after ligation
activate immune cells. TLR4 is expressed on neutrophils18
and augments their migratory responses.19 Previously, TLR4
has been demonstrated in the kidney, in the glomerulus
on mesangial cells, epithelial cells,20 and also in proximal and
distal tubular epithelial cells,21 but not in glomerular
endothelial cells (GEnCs).
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Starting from the known capacity of LPS to enhance the
activity of anti-MPO antibodies in experimental systems,6,22
we aimed to define and explore a pathogenic and mechanistic
role for TLR4 in experimental ANCA-induced glomerular
neutrophil recruitment. We studied the effect of LPS and
anti-MPO antibodies on glomerular and pulmonary neu-
trophil recruitment, which develops early in the diseases
process and is TLR4 dependent. Functional and histological
renal injury, which develops later, is also TLR4 dependent.
TLR4 expression in the glomerulus increases after LPS
and anti-MPO antibody stimulation. TLR4 is produced
by GEnCs, which are also positive for CXCL1 and CXCL2.
In vitro LPS stimulation of human glomerular cell lines
implicates GEnC as a major source of TLR4. We demonstrate
a functional relationship between CXCL1 and CXCL2,
glomerular neutrophil recruitment and subsequent renal
injury, and demonstrate that full expression of these
chemokines is TLR4 dependant. Furthermore, we demon-
strate in human cell lines that CXCL8 mRNA and protein
production increases considerably after LPS stimulation,
predominantly mediated through GEnC. Finally using bone
marrow (BM) chimeric mice we identify the individual
contributions of BM and tissue cell (TC) TLR4 to neutrophil
recruitment and glomerular injury.
RESULTS
ANCA/LPS-induced glomerular neutrophil recruitment
and lung MPO activity
Glomerular and pulmonary neutrophil recruitment was
induced by administering either highly purified LPS (hpLPS,
which specifically engages TLR4) with anti-MPO antibodies,
anti-MPO antibodies alone, or hpLPS and control (anti-
ovalbumin (OVA)) antibodies to genetically intact wild-type
(WT) C57BL/6 mice. WT mice were injected with hpLPS,
then anti-MPO or anti-OVA antibodies at 2 h and killed after
a further 3 h. LPS, anti-MPO antibodies, or both induced
glomerular leukocyte recruitment (Figure 1a). Control anti-
OVA antibodies alone had no effect on glomerular neutrophil
recruitment compared with untreated mice (untreated
mice 0.25±0.01 neutrophils/glomerular cross-section (n/gcs),
mice given anti-OVA antibodies 0.40±0.02 n/gcs). Mice in-
jected with anti-MPO antibodies alone exhibited a significant
glomerular neutrophil influx, similar to that observed in
mice treated with hpLPS and anti-OVA antibodies. Together,
hpLPS and anti-MPO antibodies synergistically increased
glomerular neutrophil recruitment. Representative photo-
micrographs of glomerular neutrophil recruitment are shown
(Figure 1c–e). In the same studies, neutrophil accumulation
in lung tissue was assessed by measuring pulmonary MPO
activity (Figure 1b). Untreated WTmice had 0.62±0.03U of
MPO activity per gram of lung tissue. Administration of either
hpLPS and anti-OVA antibodies, or anti-MPO antibodies alone
increased MPO activity to a similar degree. Administration
of hpLPS and anti-MPO antibodies led to a further increase
in lung MPO activity. Anti-OVA antibodies alone had minimal
effect (1.04±0.29U/g).
The requirement for TLR4 in maximal neutrophil recruit-
ment was confirmed by comparing TLR4/ mice with WT
mice (Figure 1f and g). Glomerular neutrophil recruitment in
untreated TLR4/ mice (0.23±0.06n/gcs) was similar to
untreated WT controls. Neutrophil recruitment in TLR4/
mice given hpLPS (with anti-OVA antibodies) was similar
to untreated TLR4/ mice. TLR4/ mice given anti-MPO
antibodies had similar glomerular neutrophil numbers to
WTmice given anti-MPO antibodies, but TLR4/ mice given
hpLPS and anti-MPO antibodies recruited fewer neutrophils
to glomeruli compared with WT given hpLPS and anti-MPO
antibodies. Similar TLR4-dependent patterns were present
in the pulmonary leukocyte recruitment, although in the
absence of TLR4 (baseline activity in untreated TLR4/
mice 0.61±0.07U/g), pulmonary MPO activity was reduced
in all three groups of mice: those given hpLPS and anti-OVA
antibodies, hpLPS and anti-MPO antibodies, as well as those
injected with anti-MPO antibodies alone.
TLR4 is expressed in murine glomeruli and produced by
murine GEnCs and human intrinsic glomerular cells
We then examined TLR4 production in murine kidneys and
human glomerular cells. TLR4 protein was readily detected
in glomeruli of WT mice treated with LPS and anti-MPO
antibodies. TLR4/ mice treated with anti-MPO antibodies
were a negative control. Using confocal microscopy TLR4 was
colocalized with GEnCs. Other glomerular cell types, probably
podocytes and possibly mesangial cells also expressed TLR4.
Illustrative photomicrographs are shown in Figure 2a–d. TLR4
mRNA expression from glomerular and tubular interstitial
compartments was assessed using laser capture microdissection
(Figure 2e; the mean value for the tubulointerstitium was
assigned a value of 1). Baseline TLR4 mRNA expression in
glomeruli was 20-fold higher than the tubulointerstitium and
increased further 24 h after LPS and anti-MPO antibodies.
There was no change in tubulointerstitial TLR4 expression.
We then analyzed TLR4 mRNA expression in human condi-
tionally immortalized GEnC (ciGEnC), podocytes, and mesangial
cell lines after stimulation with LPS (Figure 2f; the mean value
for podocyte basal TLR4 mRNA expression was assigned a
value of 1). Basal TLR4 mRNA expression was highest in
ciGEnC and not detected in mesangial cells. Flow cytometric
analysis of ciGEnC for TLR4 protein confirmed the expres-
sion of TLR4 protein (Figure 2g). After LPS, TLR4 mRNA
expression was increased at 24 h in ciGEnC, but podocyte
and mesangial cell TLR4 mRNA expression was unchanged.
CXCL1 and CXCL2 is induced in kidney tissue after
hpLPS and anti-MPO antibodies
To investigate mechanisms of glomerular neutrophil recruit-
ment we studied the neutrophil chemoattractants CXCL1
and CXCL2 in renal tissue. CXCL1 and CXCL2 expression
was assessed 5 h after both hpLPS and anti-MPO antibodies.
Compared with untreated WT mice (means for untreated
WT CXCL1 or CXCL2 mRNA expression were assigned a
value of 1), CXCL1 mRNA expression increased 5 h after
1264 Kidney International (2010) 78, 1263–1274
or ig ina l a r t i c l e SA Summers et al.: Both renal cell and leukocyte TLR4 aggravate ANCA GN
hpLPS and anti-MPO antibodies, in a partly TLR4-
dependent manner (Figure 3a). A similar pattern was seen
with CXCL2 mRNA expression, but the reduction in gene
expression in the absence of TLR4 was more profound
(Figure 3b). Immunohistochemical examination of glomeruli
for CXCL1 and CXCL2 demonstrated minimal signal in
untreated WT mice, with increased expression in all experi-
mental groups (data not shown). WT mice given hpLPS and
anti-MPO antibodies exhibited increased glomerular (with
surrounding tubular) staining of CXCL1 and CXCL2 when
compared with mice given either hpLPS with anti-OVA
antibodies, or anti-MPO antibodies alone. As hypothesized,
compared with WT mice, CXCL1 and CXCL2 staining was
decreased in TLR4/ mice given hpLPS and anti-MPO
antibodies (Figure 3c and d). Representative kidney sections
of CXCL1 (Figure 3e and f) and CXCL2 (Figure 3g and h)
immunostaining in WT and TLR4/ mice treated with
hpLPS and anti-MPO antibodies are shown.
CXCL1 and CXCL2 colocalize with GEnCs, which also
express TLR4
To determine whether murine GEnCs are a source of CXCL1
and CXCL2 production, we immunostained kidneys from
WT mice treated with LPS and anti-MPO antibodies for an
endothelial marker (CD31), TLR4, CXCL1, and CXCL2 using
confocal microscopy CXCL1 colocalized to GEnC and to
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Figure 1 | Leukocyte recruitment after anti-MPO antibody administration. (a) Glomerular neutrophil recruitment to C57BL/6 wild-type
(WT, n¼ 6) mice. Highly purified lipopolysaccharide (hpLPS) and anti-OVA (aOVA) antibodies (n¼ 6) or anti-MPO (aMPO) antibodies alone
(n¼ 6) increased glomerular neutrophil recruitment compared with untreated WT animals (n¼ 4), represented as a dotted line (Po0.001).
Co-administration of hpLPS and aMPO antibodies (n¼ 6) induced more neutrophil recruitment compared with hpLPS and aOVA antibodies
or aMPO antibodies alone. (b) Pulmonary MPO activity in WT mice. Untreated WT mice had 0.62U of MPO activity/g (dotted line); MPO
activity was increased in all antibody injected groups, compared with untreated mice. Significantly more pulmonary MPO activity was seen
in the WT mice treated with hpLPS and aMPO antibodies compared with other treatment groups. Photomicrographs representative of
glomerular neutrophil recruitment, with one glomerular neutrophil in WT mice treated with hpLPS and aOVA antibodies (c) or aMPO
antibodies alone (d), or three neutrophils in mice treated with LPS and aMPO antibodies (e) are demonstrated. In panels f and g glomerular
and lung neutrophil recruitment in WT mice are compared with recruitment in TLR4/ mice (n¼ 4). Neutrophil recruitment in untreated in
TLR4/ mice (n¼ 5) did not differ from untreated WT mice (dotted line). Glomerular neutrophil recruitment (f) and lung MPO activity (g)
decreased in TLR4/ mice compared with WT mice. *Po0.05, ***Po0.001. Original magnification x400. gcs, glomerular
cross-section; MPO, myeloperoxidase; OVA, ovalbumin; TLR, Toll-like receptor.
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glomerular cells producing TLR4. GEnC produce both TLR4
and CXCL1 (Figure 4a–f). Similarly, CXCL2 colocalized with
GEnC and cells producing TLR4. Furthermore, we demon-
strated that GEnC can produce CXCL2 and TLR4 (Figure 4g–l).
Relevant negative controls are shown in Supplementary Figure S1.
Neutrophil recruitment is CXCL1 and CXCL2 dependent
Given the enhanced expression of CXCL1 and CXCL2 in
experimental anti-MPO antibody-induced glomerular neutro-
phil recruitment, we neutralized either protein by administering
a monoclonal anti-CXCL1 antibody, an anti-CXCL2 antibody,
or isotype control 1 h before hpLPS and anti-MPO anti-
bodies and assessed neutrophil recruitment. Compared with
isotype control antibody, mice given either anti-CXCL1 or
anti-CXCL2 antibody before hpLPS and anti-MPO anti-
bodies showed significant decreases in glomerular neutrophil
recruitment and lung MPO activity (Figure 5a–b), confirming
a functional role for both CXCL1 and CXCL2 in glomerular
and pulmonary neutrophil recruitment.
TC TLR4 contributes to neutrophil recruitment
Given the expression of TLR4 in glomeruli, we defined the
contributions of BM and TC TLR4 (glomerular and lung)
expression in neutrophil recruitment by injecting LPS and
anti-MPO antibodies into TLR4 BM chimeric mice.
Chimeric mice were generated by injecting intact or deficient
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Figure 2 | TLR4 staining and expression in the kidney. Positive TLR4 staining (green) was detectable in glomeruli of WT mice treated with
LPS and anti-MPO antibodies (a). No TLR4 staining was visible in TLR4/ mice treated with anti-MPO antibodies (b). Glomeruli from WT
mice were stained with anti-CD31 antibodies to identify endothelial cells (red staining) (c). Merged image of TLR4 and endothelial cell
staining that identifies endothelial cell TLR4 production (yellow) (d). After stimulation with LPS and anti-MPO (aMPO) antibodies there
was an increase in TLR4 mRNA expression in microdissected murine glomeruli, and little change in TLR4 expression was seen in the
tubulointerstitium (n¼ 4) (e). In human conditionally immortalized ciGEnC lines, baseline TLR4 expression was increased compared with
both podocytes and mesangial cells (which did not express TLR4), n¼ 6 for all experimental groups (f). After LPS stimulation TLR4
expression increased only in endothelial cells. (g) TLR4 protein expression by ciGEnC. Flow cytometric analysis of cultured ciGEnC incubated
with no antibody (i), isotype control antibody (ii), and anti-human TLR4 antibody (iii) demonstrated TLR4 protein expression. *Po0.05,
**Po0.01, ***Po0.001. Original magnification x800. Ab, antibody; ciGEnC, conditionally immortalized glomerular endothelial cell, LPS,
lipopolysaccharide; MFI, mean florescence intensity; MPO, myeloperoxidase; TLR, Toll-like receptor; WT, wild type.
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BM into irradiated mice. WT BM transplanted into WTmice
(BMþTCþ ; ‘sham’ chimeras) were a positive control, and
TLR4 TC intact, BM TLR4 deficient (BM–Cþ ) and TC TLR4
deficient, BM intact (BMþTC–) chimeras were studied. Both
BM and TC TLR4 are required for maximal neutrophil
recruitment. Compared with BMþTCþ chimeras, glomer-
ular neutrophil recruitment was reduced in either TLR4
BM–TCþ chimeras or TLR4 BMþTC– mice (Figure 6a),
but BM-derived TLR4 has a more prominent role. Both BM
and TC TLR4 are required for maximum pulmonary
neutrophil recruitment (Figure 6b).
Glomerular CXCL1 and CXCL2 production was assessed
in kidneys of chimeric mice. Compared with ‘sham’ chimeras
(BMþTCþ ), semiquantitative assessment of CXCL1 and
CXCL2 showed a reduction in both chemokines in TLR4
BM–TCþ mice and BMþTC– mice (Figure 6c and d),
corresponding with the reduction in neutrophil recruitment.
The trend towards decreased CXCL1 and CXCL2 mRNA
expression in kidneys of BM–TCþ and BMþTC– chimeric
mice did not reach statistical significance (data not shown).
CXCL8 is produced by human GEnCs after LPS stimulation
Having established a role for TLR4 on intrinsic renal cells
in inducing CXCL1 and CXCL2 dependant experimental
glomerular neutrophil recruitment, we analyzed human
glomerular cells for CXCL8 production (CXCL1 and CXCL2
are the murine homologs of CXCL8). Baseline mean ciGEnC
mRNA expression was assigned a value of 1. Although
CXCL8 mRNA expression was increased in ciGEnC, podo-
cyte, and mesangial cells (Table 1), the relative increase was
most pronounced in ciGEnC (Figure 7a). Basal CXCL8
production was highest in podocytes (Table 1), however, after
stimulation the increase is most pronounced in ciGEnC, with
significant increases at 2, 4, and 24 h (Figure 7b). These
increases in both mRNA expression and protein production
demonstrate that GEnC are the cell type most responsible
for enhanced CXCL8 production.
The contribution of TLR4, CXCL1, CXCL2, and BM and
TC TLR4 to renal injury
Administration of hpLPS and anti-MPO antibodies (100mg/g)
induced functional renal injury (albuminuria and hematuria),
and glomerular hypercellularity with focal and segmental
lesions, including fibrin deposition in WT mice at day 6
(Figure 8a–d), significantly decreased in TLR4/ mice.
Representative photomicrographs of renal injury showing
glomerular hypercellularity and glomerular fibrin staining in
WT, reduced in TLR4/ mice are shown in Figure 8e–h.
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Figure 3 |CXCL1 and CXCL2 kidney mRNA expression and immunostaining. Using tissues from experiments detailed in Figure 1, kidney
CXCL1 mRNA expression was increased in WT mice after hpLPS and anti-OVA (aOVA) antibodies (Po0.001), n¼ 6, aMPO antibodies alone
(Po0.05), n¼ 6, and hpLPS and aMPO antibodies (Po0.001), n¼ 6. Compared with WT mice given hpLPS and aMPO antibodies, TLR4/
mice (closed bars) treated with hpLPS and aMPO antibodies expressed less CXCL1 (a), n¼ 4. Kidney CXCL2 mRNA expression in WT mice
increased after treatment with hpLPS and aMPO antibodies (Po0.05). Compared with WT mice treated with hpLPS and aMPO antibodies,
TLR4/ mice treated with hpLPS and aMPO antibodies expressed less CXCL2 (b). Immunostaining showed that CXCL1 (c) and CXCL2
(d) were significantly increased in WT mice treated with hpLPS and aMPO antibodies compared with all other groups. Representative
glomerular sections from (e) WT mice and (f) TLR4/ mice treated with hpLPS and aMPO antibodies and immunostained for CXCL1 are
shown. Similarly treated (g) WT and (h) TLR4/ glomeruli immunostained for CXCL2 are shown. Black arrowheads represent areas where
staining intensity was most pronounced. Increased staining was seen in WT mice. *Po0.05, **Po0.01, ***Po0.001. Original magnification
 400. hpLPS, highly purified lipopolysaccharide; MPO, myeloperoxidase; OVA, ovalbumin; WT, wild type.
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As CXCL1 and CXCL2 were important in glomerular
neutrophil recruitment, we defined their role in the
development of histological and functional renal injury by
extending studies to day 6. Compared with mice given
ANCA/LPS and isotope control antibodies, albuminuria
and hematuria were decreased after the administration of
anti-CXCL2 antibody and ANCA/LPS, whereas a trend to
decreased injury was seen after the administration of anti-
CXCL1 antibody (Figure 9a and b). Albuminuria, measured
in the initial 24 h in mice administered control antibody and
ANCA/LPS (170±39 mg/24 h) was decreased in mice given
anti-CXCL1 antibody and ANCA/LPS (55±14 mg/24 h,
Po0.001) and anti-CXCL2 and ANCA/LPS (87±10 mg/
24 h, Po0.01). Glomerular histological injury (Figure 9c
and d) was attenuated after the administration of CXCL1 or
CXCL2 neutralizing antibodies, though reduced hypercellu-
larity after anti-CXCL1 antibody did not reach statistical
significance.
Having demonstrated a role for both BM and glomerular
TLR4 in neutrophil recruitment, we confirmed that both
are required for maximal renal injury. Compared with
BMþTCþ ‘sham’ chimeras, albuminuria was decreased
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Figure 4 |Glomerular endothelial cell, CXCL1, CXCL2, and TLR4 colocalization. Kidneys from WT mice given LPS and anti-MPO
antibodies were stained for (a) CD31 (blue), (b) TLR4 (green), and (c) CXCL1 (red). Endothelial cells and CXCL1 colocalized (magenta) (d).
CXCL1 and TLR4 also colocalized (yellow) (e), and a merged three-color image showed that some endothelial cells were positive for both
CXCL1 and TLR4 (white) (f). To assess CXCL2 production kidneys were stained for (g) CD31 (blue), (h) TLR4 (green), and (i) CXCL2 (red).
CXCL2 colocalized with glomerular endothelial cells (magenta) (j) and TLR4 (yellow) (k). Merged three-color image showing that some
endothelial cells were positive for both CXCL2 and TLR4 (white) (l). Original magnification x800. LPS, lipopolysaccharide; MPO,
myeloperoxidase; TLR, Toll-like receptor; WT, wild type.
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in both BM–TCþ and BMþTC– mice, (Figure 10a and b;
trends to reduction in hematuria did not reach significance).
Histological injury was reduced in BM–TCþ and BMþTC–
mice with less glomerular fibrin deposition and hypercellu-
larity (Figure 10c and d).
DISCUSSION
These studies define roles for both BM cell and TC-derived
TLR4 in the pathogenesis of neutrophil recruitment in LPS/
anti-MPO antibody renal and lung injury, and the roles of
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Figure 5 |Neutrophil recruitment after neutralization of
CXCL1 or CXCL2. Administering CXCL1 (n¼ 4) or CXCL2 (n¼ 4)
neutralizing antibodies prior to the administration of hpLPS and
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recruitment (a) and lung MPO activity (b) relative to control-
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Figure 6 |Assessment of glomerular leukocyte recruitment,
lung MPO activity, and glomerular chemokine staining
in BM chimeric wild type (WT)-WT mice (bone marrow
(BM)þ , tissue cell (TC)þ , n¼ 8), TLR4/-WT mice
(BM–TCþ , n¼ 8), and WT-TLR4/ mice (BMþ TC–, n¼ 8)
injected with hpLPS and anti-MPO (aMPO) antibodies.
Glomerular neutrophil recruitment (a) was decreased in both
BM–TCþ and BMþ TC– compared with BMþ TCþ mice. There
was decreased glomerular neutrophil recruitment in BM–TCþ
mice compared with BMþ TC– mice. Lung MPO activity was
decreased in both BM–TCþ and BMþ TC– mice compared with
BMþ TCþ mice (b). Kidney CXCL1 (c) and CXCL2 (d)
immunostaining was decreased in BM–TCþ and BMþ TC– mice
compared with BMþ TCþ mice. *Po0.05, **Po0.01,
***Po0.001. gcs, glomerular cross-section; MPO,
myeloperoxidase.
Table 1 | CXCL8 mRNA and protein production in
human glomerular cell lines at 0, 2, 4, and 24h after
lipopolysaccharide stimulation
CXCL8 mRNA 0h 2h 4h 24h
ciGEnC 1.0±0.1 46.2±2.0## 33.4±2.6## 15.5±1.8##
Podocytes 2.3±0.2 28.0±1.9## 19.8±0.8## 17.9±0.9##
Mesangial cells 0.0±0.0 0.4±0.0## 0.2±0.0# 0.1±0.0
CXCL8 protein (ng/ml) 0 h 2 h 4h 24h
ciGEnC 2.3±0.1 3.0±0.1 9.0±0.5## 35.8±1.9##
Podocytes 27.1±1.3 24.5±1.8 28.5±1.7 40.8±4.3#
Mesangial cells 0.2±0.0 0.3±0.0 0.3±0.0 0.5±0.0##
Abbreviation: ciGEnC, conditionally immortalized glomerular endothelial cells.
Baseline mRNA expression in ciGEnC was assigned a value of 1. Increased expression is
seen in all cell lines, most pronounced at 2h. CXCL8 protein production also increases in
each cell type, most pronounced after 24h. #Po0.01 ##Po0.001 compared with t=0h.
a ciGEnC
ciGEnC
60
40
20
20
0
0
Time (h) after LPS stimulation
Time (h) after LPS stimulation
0
0
2
2
4
4
24
24
b
10
***
***
***
***
*
***
Fo
ld
 in
cr
ea
se
Fo
ld
 in
cr
ea
se
Podocytes
Mesangial cells
Podocytes
Mesangial cells
Figure 7 |CXCL8 mRNA and protein production in human
glomerular cell lines. After lipopolysaccharide (LPS) stimulation,
CXCL8 mRNA expression was increased in all three cell types, most
pronounced in conditionally immortalized glomerular endothelial
cells (ciGEnC) (a). Similarly, ciGEnC produced the greatest
proportional increase in CXCL8 protein production (b), n¼ 6 for all
experimental groups. Absolute values (in pg/ml) of CXCL8
measurements are shown in Table 1. *Po0.05, ***Po0.001.
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CXCL1 and CXCL2. After stimulation, the glomerulus is the
major site of TLR4 expression in the kidney, whereas GEnC
are the cell type most responsible. Both BM and TC TLR4 are
required for full expression of CXCL1 and CXCL2, and
maximal neutrophil recruitment. Murine GEnC are a source
of TLR4, CXCL1, and CXCL2, with some GEnC producing
both TLR4 and neutrophil chemoattractants. Using human
glomerular cells, we demonstrated that after stimulation
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Figure 8 | Functional and histological renal injury in WT and
TLR4/ mice treated with LPS and anti-MPO antibodies.
At 6 days after the administration of aMPO antibody/LPS
24 h albuminuria (a), dipstick hematuria (b), glomerular fibrin
deposition (c), and glomerular hypercellularity (d) was attenuated
in TLR4/ mice (n¼ 6) compared with WT controls (n¼ 6).
The dotted line in (a) and (d) represents mean values in untreated
WT mice. Representative figures are shown demonstrating
glomerular injury in WT mice (e) compared with TLR4/ mice (f).
More glomerular fibrin deposition was seen in WT mice (g)
compared with TLR4/ mice (h). *Po0.05, **Po0.01,
***Po0.001. Original magnification x400. gcs, glomerular
cross-section; LPS, lipopolysaccharide; MPO, myeloperoxidase;
TLR, Toll-like receptor; WT, wild type.
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Figure 9 | Functional and histological renal injury in WT mice
treated with LPS and anti-MPO antibodies with previous
neutralization of CXCL1 (n¼ 6) and CXCL2 (n¼ 6). Compared
with control antibody–treated mice (n¼ 6), 24 h albuminuria
(a) and dipstick hematuria (b) were significantly decreased after
CXCL2 neutralization; trends after administration of CXCL1
neutralizing antibody did not reach significance. Less glomerular
fibrin deposition (c) was evident with neutralization of either CXCL1
or CXCL2, whereas compared with control antibody–treated mice,
hypercellularity was decreased with neutralization of CXCL2 (d).
*Po0.05, **Po0.01, ***Po0.001. Ab, antibody; LPS,
lipopolysaccharide; MPO, myeloperoxidase; WT, wild type.
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Figure 10 | Functional and histological renal injury in BM
chimeric mice wild type (WT)-WT mice (bone marrow
(BM)þ , tissue cell (TC)þ , n¼ 7), Toll-like receptor (TLR4/)
-WT mice (BM–TCþ , n¼ 6), and WT-TLR4/ mice
(BMþ TC–, n¼ 7) injected with hpLPS and aMPO antibodies.
Compared with ‘sham chimeras’ (BMþ TCþ ) 24 h albuminuria
(a) was decreased in BM–TCþ and BMþ TC– chimeras. There was
a non-significant trend to decrease in dipstick hematuria (b).
Glomerular fibrin deposition (c) and glomerular hypercellularity
(d) was decreased in BM–TCþ and BM–TCþ chimeric mice
compared with sham chimeras BMþ TCþ . *Po0.05, **Po0.01,
***Po0.001.
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GEnC are largely responsible for the increase in CXCL8
expression and protein production. In vivo studies at a later
time point confirmed the functional relevance of both
immune cell- and TC-derived TLR4, and of neutrophil
chemoattractants, especially CXCL2.
Experimental anti-MPO antibody-induced GN is neutro-
phil dependent.4 Neutrophils express TLR4, and LPS that
engages TLR4, is a potent stimulus for neutrophil activation.
TLR4 ligation has pleiotropic effects on neutrophils including
neutrophil adhesion,23,24 delayed apoptosis, enhanced che-
mokine production and increased superoxide generation.25
In the current studies, the first series of experiments showed
that administering both hpLPS and anti-MPO antibodies
led to increased glomerular neutrophil recruitment and
lung MPO activity. The effects of hpLPS on neutrophil
recruitment were not seen in TLR4/ mice. These studies
are in accordance with previous work showing that LPS had
the capacity to markedly increase anti-MPO antibody-
induced injury in mice.6,26
In the current studies, we used three separate techniques
to determine the glomerular cell types responsible for TLR4
production. First, using confocal microscopy, we demon-
strated that TLR4 is present in murine glomeruli and
colocalizes with GEnC. Other glomerular cells also express
TLR4 in this model. Second, using microdissected glomeruli,
TLR4 mRNA expression was quantitated in glomeruli
and the tubulointerstitium. After the administration of LPS
and anti-MPO antibodies glomerular, but not tubulointer-
stitial TLR4 expression was increased. Third, using isolated
human glomerular cells, we demonstrated that GEnC express
significant amounts of TLR4, and that enhanced mRNA
expression after stimulation is attributable to GEnC.
Therefore, GEnC are significant sources of glomerular
TLR4 expression after the administration of LPS and anti-
MPO antibodies. The sites of intrarenal TLR4 production,
both in the glomerulus and the tubulointerstitium have been
addressed in several studies in other experimental models.
TLR4 has been localized to the glomerulus in other models
of renal disease.20,27,28 In situ hybridization showed that
mesangial and epithelial cells can express TLR4,27 whereas
in experimental cryoglobulinemic GN podocytes express
TLR4.20 Studies assessing TLR4 in murine models of
tubulointerstitial injury have demonstrated TLR4 mRNA
production from primary renal tubular epithelial cells,29
whereas confocal microscopy has suggested TLR4 is present
in proximal collecting tubules.30 From the existing literature
and the current studies, it is clear that TLR4 expression from
intrinsic renal cells can vary according to the nature of the
injurious stimulus. In the current studies, the results of a
combination of in vivo and in vitro studies imply a role for
the glomerular endothelium in TLR4 responses in the context
of LPS and anti-MPO antibodies as initiators of injury.
In vivo murine models have shown that the chemokines
CXCL1 and CXCL2 directs neutrophil recruitment to the
cornea,31 peritoneum,32,33 and the joint.34 The addition of
LPS to antiglomerular basement membrane (GBM) globulin
enhances heterologous renal injury.27,35 Furthermore, Brown
et al.,27 demonstrated that neutralizing CXCL1 and CXCL2,
which was TLR4 mediated and produced by renal cells,
resulted in decreased glomerular injury. We have demon-
strated that renal CXCL1 and CXCL2 expression (mRNA and
protein) increases in a TLR4-dependent manner, both of
which are produced by GEnC. The receptor for CXCL1 and
CXCL2, CXCR2, is present on neutrophils, but LPS does not
induce its expression or alter migration induced by
neutrophil chemoattractants.23,36 The current studies show
that CXCL1 and CXCL2 direct anti-MPO antibody glomer-
ular and pulmonary neutrophil recruitment, as neutralizing
CXCL1 and CXCL2 decreased glomerular neutrophil recruit-
ment and lung MPO activity early, and functional and
histological renal injury later in the disease.
Both BM-derived cells37 and an activated glomerular
endothelium38,39 are thought to be important in glomerular
neutrophil recruitment in GN induced by anti-MPO
antibodies. The current studies demonstrate that both BM
and TC TLR4 are required for maximal glomerular and lung
neutrophil requirement, underlying separate roles in the
disease process. These effects within the kidney extended out
to at least 6 days, wherein mice deficient in either BM cell or
TC TLR4 exhibited less injury, even in the face of more
profound initial decrease in glomerular neutrophil recruit-
ment in BM–TCþ mice. As CXCL1 and CXCL2 staining was
decreased in BM–TCþ mice and BMþTC– mice, both BM
and TC-derived TLR4 are important in the renal production
of CXCL1 and CXCL2, required for glomerular neutrophil
recruitment. Neutralizing CXCL2 at the induction of injury
resulted in attenuated functional and histological glomerular
injury after 6 days; the effects of CXCL1 blockade were less
prolonged. Although the current studies did not assess the
cell type in the lung that produces neutrophil chemoattrac-
tants, previous studies have demonstrated that CXCL1 and
CXCL2 are produced by Clara cells (non-ciliated bronch-
oalveolar epithelial cells in the distal airways).40 Previous
studies analyzing lung MPO activity to quantitate neutrophil
recruitment in TLR4 chimeric mice have yielded conflicting
results, with one study implicating TCs,41 whereas another
showed BM cell TLR4 to be important.42 In experimental
anti-MPO antibody-induced neutrophil recruitment MPO
activity is decreased in both BM–TCþ and BMþTC–
chimeric mice.
Observations in human renal biopsies suggest a pathogenic
role for CXCL8, the key neutrophil-attracting chemokine in
ANCA GN.15 Previous studies have suggested that CXCL8
can be produced by ‘generic’ macrovascular endothelial cells
(HUVECs),43 and cultured human mesangial cells.44 We
compared CXCL8 production by different human glomerular
cells, including ciGEnC, concurrently, in a single study.
Although baseline expression of CXCL8 mRNA and protein
production was higher in podocytes; ciGEnC showed the most
significant increase in expression and production after stimula-
tion, suggesting that during inflammation GEnC produce
CXCL8, which is responsible for neutrophil recruitment.
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We have demonstrated a pivotal role for both BM and
intrinsic renal cell TLR4 in glomerular and lung neutrophil
recruitment and injury in experimental ANCA disease.
Maximal neutrophil recruitment is dependant on CXCL1
and CXCL2, TC expression, which is TLR4 dependant.
Therefore, in addition to immune cell TLR4-mediated
activation and recruitment, the current studies demonstrate
a role for the glomerular endothelium, which involves GEnC
TLR4 expression, and CXC chemokine production, that
enhances neutrophil recruitment. Results from these studies
add to evidence linking infection to autoimmune GN and
provide evidence for possible benefits of TLR inhibition in
immune glomerular disease.
MATERIALS AND METHODS
Generation of mouse anti-MPO immunoglobulin G (IgG),
control mouse anti-OVA IgG, and hpLPS
Murine MPO (mMPO) was generated as described previously.45
Globulin was precipitated (50% ammonium sulfate) and IgG
affinity purified by fast protein liquid chromatography and dialyzed
against PBS. For anti-OVA antibodies, Mpo/ mice were im-
munized with OVA using the same protocol. Endotoxin concentra-
tion measuredo0.01 ng/ml, Limulus Amebocyte Lysate E-TOXATE
(Sigma-Aldrich, St Louis, MO). For in vivo experiments LPS-L2654
(Sigma-Aldrich) was repurified to ensure TLR4 specificity.46
Experimental design and statistical analyses
Eight week old male WT (C57BL/6 (CD45.2) and for some chimeric
studies congenic CD45.1 mice) and TLR4/ mice were used. Mice
were from Monash University Animal Services (Melbourne,
Australia), TLR4/ mice originally from Professor S Akira.47
Studies adhered to the National Health and Medical Research
Council of Australia guidelines for animal experimentation. For
neutrophil accumulation, mice were injected intraperitonally with
hpLPS (10mg), followed 2 h later by intravenous injection of IgG
(anti-MPO antibodies 50 mg/anti-OVA (control) antibodies 50 mg),
3 h later animals were killed. For studies analyzing functional and
histological renal injury, mice were injected with hpLPS 10 mg
followed by anti-MPO antibodies (100mg/g) and killed on day 6.
Neutralizing monoclonal antibodies directed against CXCL1 or
CXCL2 (MAB 453 and MAB 452 respectively; R&D systems,
Minneapolis, MN, USA) were used with appropriate control
antibodies, (rat IgG2a and IgG2b). At 1 h before the disease
induction, mice were administered; anti-CXCL1-Ab (100 mg), anti-
CXCL2-Ab (100 mg), or control Ab (100 mg) intravenous. BM (BM)
chimeric mice were generated as previously described.48 Flow
cytometry demonstrated 492% reconstitution. Data are expressed
as mean ± s.e.m. Groups of data were analyzed using student’s t-
test for analysis of two groups and one-way ANOVA (Tukey’s post
test) for more than two groups of data. GraphPad Prism software
(GraphPad Software, San Diego, CA, USA) was used to analyze the
data. A P-value of o0.05 was considered significant.
Assessment of glomerular neutrophil accumulation, CXCL1
and CXCL2, histological and functional renal injury and
pulmonary MPO
Neutrophils were demonstrated by immunoperoxidase staining of
periodate lysine paraformaldehyde fixed tissue as previously described,49
a minimum of 50 glomeruli were assessed. Results are expressed as
neutrophils per glomerular cross-section (n/gcs). CXCL1 and
CXCL2 immunohistochemical staining was performed as previously
described.50 To assess the intensity of glomerular and juxtaposed
tubular CXCL1 and CXCL2 staining a semiquantative intensity
staining scale was used, previously described and published.50
Values are expressed as numbers ranging from 0–4, where 0: no
staining seen; 1: staining o25%; 2: 25–50%; 3: 51–75%; and 4:
475% of the glomerulus and adjacent tubules.
For histological assessment, 40 consecutive glomeruli/mouse
were examined. Kidneys were fixed with Bouin’s fixative, embedded
in paraffin and stained with Periodic Acid-Schiff reagent. Fibrin
staining was performed as previously described.51 and results
expressed as percentage of glomeruli with fibrin deposition.
Albuminuria was measured on 24 h urine collections using a
Mouse Albumin ELISA Quantification Kit (Bethyl Laboratories,
Montgomery, TX, USA). Hematuria was measured using urinary
dipstix (Combur Tests, Roche, Basel, Switzerland). Lung MPO was
used to assess pulmonary neutrophil accumulation as previously
described.52 One unit of MPO activity was defined as a change in
D460 of 1.0 after 2min; results are expressed as U of MPO activity/g
of lung tissue (U/g).
For colocalization experiments using confocal microscopy, kidneys
were perfused and fixed with zinc fixative, paraffin embedded and
sectioned (3mm). For endothelial cell/TLR4 colocalization, sections
were blocked (10% chicken and donkey serum in 5% bovine serum
albumin), then incubated with rabbit anti-mouse TLR4 (10 mg/ml,
Invitrogen, Carlsbad, CA, USA) and rat anti-mouse CD31 (1:50,
BD Biosciences, San Jose, CA, USA), followed by chicken anti-rabbit
Alexa Fluor 488 and donkey anti-rat Alexa Fluor 594 (both 1:200,
Molecular Probes, Invitrogen, Carlsbad, CA, USA). For colocaliza-
tion of neutrophil chemokines, TLR4 and endothelial cells, anti-
CD31 antibodies were followed by donkey anti-rat Alexa Fluor 647
(1:200, Molecular Probes). For CXCL1 colocalization, antibodies
were rabbit anti-mouse TLR4 (20mg/ml), and goat anti-mouse
CXCL1 (20 mg/ml, R&D Systems), then chicken anti-rabbit Alexa
Fluor 488 and chicken anti-goat Alexa Fluor 594 (1:200, Molecular
Probes). For CXCL2 co-localization, antibodies were goat anti-mouse
TLR4 (20 mg/ml, Santa Cruz Biotechnology, Santa Cruz, CA, USA),
with chicken anti-goat Alexa Fluor 488, and rabbit anti-mouse
CXCL2 (10 mg/ml, R&D Systems). CXCL2 signal was amplified with
swine anti-rabbit HRP conjugated antibody (1:100, DAKO, Glostr-
up, Denmark) with a Cyanine-3-Tyramide Signal Amplification kit
(PerkinElmer, Waltham, MA, USA). For all samples concurrent
negative controls included substituting the primary antibodies for
non-immune goat, rat or rabbit IgG, and additionally for TLR4,
using TLR4/ mice receiving hpLPS and anti-MPO antibodies.
Images were acquired using a Nikon C1 confocal laser scan head
attached to a Nikon Ti-E inverted microscope (Nikon, Tokyo, Japan)
using 488, 561, and 637nm lasers. Single plane 512 512 12-bit
images were captured in a line sequential manner (three line
averaging). Confocal images were converted using Macbiophotonics
Image J software (NIH, Bethesda, MD, USA).
Culture of human glomerular cells and assessment
of TLR4, interleukin-8, CXCL1 and CXCL2 mRNA
and protein
Human ciGEnC,53 podocytes54,55 and human immortalized glo-
merular mesangial cells, kindly provided by Dr Banas (Ludwig-
Maximilians University, Munich, Germany),56 were cultured.
Cells were treated with 1 mg/ml LPS (Escherichia Coli, serotype
O26:B6; Sigma-Aldrich) for 2, 4, or 24 h, medium, collected and
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cells lysed for RNA isolation. For laser microdissection, glomeruli
(2.72±0.29 106mm2) and surrounding tubulointerstitial tissue
(2.88±0.25 106mm2) were dissected from renal cryosections of
anti-MPO IgG/LPS treated mice from a previous study26 using the
Laser Robot Microbeam System (P.A.L.M. Micro laser Technology,
Bernried, Germany) described previously.57
Real-time PCR analysis on complementary DNA was carried out
using the ABI Prism 7900HT Sequence Detection System (Applied
Biosystems, Nieuwerkerk a/d IJssel, The Netherlands) using assay on
demand primer-probe sets for TLR4 (Hs00152939_m1), interleu-
kin-8 (Hs00174103_m1), and GAPDH (Hs99999905_m1; glycer-
aldehyde 3-phosphate dehydrogenase) as the house keeping gene.
For measurement of CXCL1 and CXCL2 real-time PCR was as
previously described, standardized to 18S, expressed as a fold
increase relative to untreated WT mice.58
For fluorescence-activated cell sorting analysis of TLR4 protein
expression on ciGEnC 2.3 105 cells were cultured for 5 days,
subsequently, TLR4 protein was detected using PE-Cy7 anti-human
TLR4 antibody (eBioscience, San Diego, CA, USA). Mean
fluorescence intensity of PE-Cy7 was measured using a LSR-II flow
cytometer. CXCL8 was measured in culture medium from ciGEnC,
podocytes and mesangial cells using ELISA (R&D systems).
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